ONCOBONE VENTURES
Updated 43 days ago
Private Limited Company
- Active - 13249925 (CH)
- Age: 3 years
- ID: 50225623/15
First Floor, Smith House, George Street, Nailsworth, Gloucestershire, GL6 0AG, United Kingdom
• 72110 - Research and experimental development on biotechnology
OncoBone Ventures was established in UK in March 2021 by four directors/co-founders with strong scientific and corporate experience in oncology drug development. The company develops novel therapies for cancer patients with bone metastases. Global cancer burden and cancer deaths are rapidly increasing, and metastases are the primary cause of cancer death. Bone is a major site of metastasis in several cancers, with breast and prostate cancer being most affected. Only about 5% of cancer patients with bone metastases are alive five years after the diagnosis. In the USA alone, over 350,000 cancer patients die each year from bone metastases. With no effective therapies available, bone metastases are currently incurable and a high unmet medical need, and such therapies would have a huge impact on the healthcare sector... OncoBone Ventures seeks investor funding for our drug development programs. The company expects to generate profitable business within three years after completing the..
Also known as: ONCOBONE VENTURES LIMITED
Registration numbers: 13249925 (CH)